Novartis Seeks Marketing Assistant for Haematology Team in London CITY – May 3, 2024 – Global healthcare leader Novartis is hiring a Marketing Assistant for their haematology team in London, as announced today. Teh role, based in London, aims to support the company’s efforts in delivering value to customers and patients. The primary responsibilities will … Read more
Over the past few years interest has ramped up across industry and academia in bringing advanced cell therapy modalities such as chimeric antigen receptor T-cell (CAR-T) therapy to the field of autoimmune disease, with many directing their initial efforts at systemic lupus erythematosus (SLE) and lupus nephritis (LN). Thus far, late 2024 and early 2025 … Read more
According to the Michael J. Fox Foundation, almost 1 million people in United States live with Parkinson disease (PD) and more than 6 million people in the world live with PD. Notably, the symptoms of PD and their severity vary widely, and can be different for every person. Although some treatment options for the disease … Read more
This article originally appeared on our sister site, Ophthalmology Times Europe®. Nanoscope Therapeutics’ MCO-010 (sonpiretigene isteparvovec), an investigational ambient-light activatable multi-characteristic opsin (MCO) gene therapy, showed the ability to restore vision in patients with retinitis pigmentosa (RP) in clinical data published Molecular Therapy.1 In the paper, which is entitled “A synthetic opsin restores vision in patients … Read more
According to the Colorectal Cancer Alliance, colorectal cancer is the second deadliest cancer in the United States. In 2025 alone, 52,900 people in the US are expected to die from colorectal cancer. Although screening efforts and lifestyle changes have helped to reduce death rates during the past few decades, substantial unmet need remains, especially for … Read more
MIAMI, Feb. 14, 2025 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the Emerging Growth Virtual Conference taking place February 18-19, 2025. Details for the Company’s presentation: Date: February 19, 2025 … Read more
Researchers led by the University of California, San Francisco (UCSF), report a new approach that deprived tumors of nutrition in cancer models, and may one day lead to a new approach that can be further developed and personalized for specific cancers and patients. Their findings are published in Nature Biotechnology in an article titled, “Implantation … Read more
For all of 2024, our team was following the clinical development of targeted and novel engineered approaches to the treatment of patients with various medical disorders. These efforts included holding in-depth conversations with experts in the clinical care of these individuals, as well as in cell and gene therapy development, culminating in our coverage of … Read more